Evaluation Of Clinical Pharmacy Services in Patients Receiving Antithrombotic Treatment

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

November 30, 2022

Conditions
Cardiovascular DiseasesDrug Use
Interventions
BEHAVIORAL

Intervention Group: Group to which the clinical pharmacist makes recommendations

The drugs administered to patients within 24-48 hours after hospitalization were recorded. A detailed medication review will be conducted by the clinical pharmacist during the participants' hospitalization.As a result of a comprehensive evaluation, recommendations were made to doctors regarding drug-related problems and were recorded.

Trial Locations (1)

34096

Bezmialem Vakıf Üniversitesi, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT06193473 - Evaluation Of Clinical Pharmacy Services in Patients Receiving Antithrombotic Treatment | Biotech Hunter | Biotech Hunter